Stay updated with breaking news from Jamesg Cullem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Boston (December 12, 2023) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized
Allarity Therapeutics Gaining Momentum? Hits Multiple Milestones Including ...
Allarity Therapeutics (NASDAQ: ALLR) is a biotechnology company focused on realizing true personalized cancer care by developing targeted cancer therapies coupled with companion diagnostics.
NEWS RELEASE Allarity Therapeutics CEO Letter to Shareholders 8/11/2023 BOSTON, August 11, 2023 ...
Ixabepilone produced clinical benefit in patients with metastatic breast cancer selected for treatment with the DRP®-IXEMPRA® companion diagnostic candidate.